Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in September, 2020 for $1,204,513.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA192435-04A1 | Phase II | 1,204,513 | September 3, 2020 | |||||||
A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in September, 2015 for $1,620,622.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA192435-02 | Phase II | 1,620,622 | September 1, 2015 | |||||||
A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. in June, 2014 for $1,988,027.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI095159-02A1 | Phase II | 1,988,027 | June 15, 2014 | |||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $199,398.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120074 | Phase I | 199,398 | ||||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $120,511.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI053021-01 | Phase I | 120,511 | ||||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $130,810.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI065039-01 | Phase I | 130,810 | ||||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $126,861.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI053910-01 | Phase I | 126,861 | ||||||||
A SBIR Phase II contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $750,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI053910-02 | Phase II | 750,000 | ||||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $218,442.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 218,442 | |||||||||
A SBIR Phase I contract was awarded to AVANT IMMUNOTHERAPEUTICS, INC. for $103,263.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 103,263 |